More evidence emerges that the use of statins to lower cholesterol may be counterproductive in preventing heart failure. Though cholesterol levels may be lowered, statins can inhibit vitamin K production, a substance critical to preventing plague buildup in arteries.
Using surrogate end-points for clinical trials represents a massive boost for pharmaceutical company profits. So, they work hard, behind the scenes, to ensure that this happens